Bvf Inc Annexon, Inc. Transaction History
Bvf Inc
- $3.27 Billion
- Q2 2024
A detailed history of Bvf Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Bvf Inc holds 7,000,000 shares of ANNX stock, worth $45.9 Million. This represents 1.05% of its overall portfolio holdings.
Number of Shares
7,000,000
Previous 7,000,000
-0.0%
Holding current value
$45.9 Million
Previous $50.2 Million
31.66%
% of portfolio
1.05%
Previous 1.5%
Shares
2 transactions
Others Institutions Holding ANNX
# of Institutions
158Shares Held
102MCall Options Held
3.61MPut Options Held
1.08M-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$55.3 Million8.98% of portfolio
-
Satter Management Co., L.P.7.41MShares$48.5 Million76.44% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$43.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$42.1 Million2.05% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.99MShares$39.2 Million0.08% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $312M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...